Therapeutic Use – Biovorin 15 contains Leucovorin Calcium, a folinic acid derivative used to reduce the toxic effects of methotrexate and enhance the effectiveness of chemotherapy medicines like 5-fluorouracil (5-FU).

Rescue Therapy – Commonly prescribed as a “rescue agent” after high-dose methotrexate therapy to protect healthy cells.

Cancer Treatment Support – Enhances the anti-cancer activity of 5-FU in colorectal and other cancers.

Convenient Dosage – 15 mg tablet strength allows for accurate dosing as prescribed by the physician.

Breast Cancer Treatment – Altraz contains Anastrozole, an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Reduces Estrogen Levels – Works by lowering estrogen production in the body, slowing or stopping the growth of estrogen-dependent cancer cells.

Prevents Cancer Recurrence – Often prescribed after surgery, radiation, or chemotherapy to reduce the risk of breast cancer coming back.

Convenient Oral Dosage – Available in tablet form for easy daily administration.

Effective Cancer Treatment – Capegard 500 contains Capecitabine, an oral chemotherapy drug used in the treatment of breast, colorectal, and gastric cancers.

Targeted Action – Converts into 5-fluorouracil (5-FU) inside cancer cells, disrupting DNA synthesis and slowing the growth of tumor cells.

Oral Convenience – Unlike traditional chemotherapy, it comes in a tablet form, allowing at-home administration under medical guidance.

Used Alone or in Combination – Can be prescribed as a single agent or in combination with other chemotherapy drugs for improved outcomes.

Supports Kidney Health – Aplazar contains Alpha Ketoanalogue of essential amino acids, specially formulated to help patients with chronic kidney disease (CKD).

Reduces Uremic Toxins – Helps lower the accumulation of harmful nitrogenous waste in the blood by reducing protein breakdown.

Maintains Nutritional Balance – Provides essential amino acids in a form that minimizes strain on the kidneys, helping maintain muscle mass and overall nutrition.

Slows CKD Progression – Often prescribed along with a low-protein diet to delay the progression of kidney damage.

Chronic Hepatitis B Treatment – Entavir 0.5 contains Entecavir, an antiviral medicine effective in managing chronic hepatitis B virus (HBV) infection.

Reduces Viral Load – Inhibits HBV replication, thereby lowering viral load in the body and slowing the progression of liver damage.

Protects Liver Health – Helps prevent complications such as liver cirrhosis, fibrosis, and hepatocellular carcinoma (liver cancer).

Convenient Dosage – Available in an easy-to-take 0.5 mg oral tablet for once-daily use.

Manages High Triglycerides – Bilypsa contains Saroglitazar, an innovative dual PPAR α/γ agonist that helps reduce elevated triglyceride and cholesterol levels.

Useful in Diabetic Dyslipidemia & NAFLD/NASH – Indicated for managing diabetic dyslipidemia, hypertriglyceridemia, and improving liver health in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Improves Insulin Sensitivity – Enhances glycemic control and insulin sensitivity, making it beneficial for patients with type 2 diabetes and related metabolic conditions.

Liver & Heart Protection – Supports cardiovascular health by lowering lipid levels and helps reduce fat accumulation in the liver.

Iron Chelation Therapy – Desirox 500 contains Deferasirox, an oral iron chelator used to reduce chronic iron overload caused by frequent blood transfusions.

Protects Vital Organs – Helps prevent iron-induced damage to the heart, liver, and endocrine organs, ensuring long-term health in transfusion-dependent patients.

Convenient Oral Tablet – Unlike traditional chelation methods, Desirox is taken orally, improving patient compliance and comfort.

Wide Clinical Use – Commonly prescribed in conditions like thalassemia major, sickle cell anemia, and other chronic anemias requiring transfusions.

Cancer Therapy – 6-MP contains Mercaptopurine, a chemotherapy medicine mainly used in the treatment of acute lymphoblastic leukemia (ALL).

Stops Cancer Cell Growth – Works as an antimetabolite by interfering with DNA and RNA synthesis, preventing cancer cells from multiplying.

Maintains Remission – Often prescribed for long-term maintenance therapy in leukemia to help keep the disease under control.

Oral Convenience – Available as an oral tablet, making it easier for patients to take as part of their treatment plan.

Powerful Oral Anticoagulant – Apigat 5 contains Apixaban 5 mg, a direct oral anticoagulant (DOAC) that helps prevent harmful blood clot formation.

Stroke & Embolism Prevention – Prescribed to lower the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

DVT & PE Treatment – Effectively used for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Post-Surgery Protection – Helps prevent blood clots following hip or knee replacement surgery, reducing recovery risks

Oral Anticoagulant – Apigat 2.5 contains Apixaban, a direct oral anticoagulant (DOAC) that helps prevent blood clot formation.

Prevents Stroke & Clots – Commonly prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

DVT & PE Management – Used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), especially after hip or knee replacement surgery.

Convenient Oral Dose – 2.5 mg strength offers an easy-to-take oral alternative to injectable anticoagulants

Therapeutic Use – Albavir is a fixed-dose combination of Abacavir Sulphate and Lamivudine, two antiretroviral medicines used in the management of HIV infection.

Dual Mechanism – Both drugs belong to the NRTI (Nucleoside Reverse Transcriptase Inhibitors) class, working together to block the replication of the HIV virus in the body.

Improves Immunity – Helps lower viral load and increases CD4 cell counts, thereby strengthening the immune system.

Convenient Dosage – Combined formulation reduces pill burden, making treatment easier to follow.

Therapeutic Use – Endace 160 contains Megestrol Acetate, a synthetic progestin primarily used in the management of breast cancer, endometrial cancer, and loss of appetite/weight associated with chronic illness.

Appetite Stimulant – Helps improve appetite and promote weight gain in patients suffering from cancer-related anorexia or cachexia.

Cancer Management – Provides palliative care benefits in hormone-responsive cancers like breast and endometrial cancer.

Convenient Dosage – 160 mg tablet strength ensures effective treatment under medical supervision.

Therapeutic Use – Duovir is a fixed-dose combination of Lamivudine and Zidovudine, both belonging to the NRTI (Nucleoside Reverse Transcriptase Inhibitors) class, used in the management of HIV infection.

Dual Antiretroviral Action – Works by blocking the activity of reverse transcriptase, an enzyme essential for HIV replication, thereby reducing viral load.

Strengthens Immunity – Helps increase CD4 cell counts, improving immune function and lowering the risk of opportunistic infections.

Convenient Combination Therapy – Combines two active drugs in one tablet, reducing pill burden and improving treatment compliance.

Broad-Spectrum Antifungal – Candipoz GR contains Posaconazole, effective against a wide range of fungal infections including aspergillosis, candidiasis, and other invasive fungal infections.

Prevention & Treatment – Used for both prophylaxis in high-risk patients (e.g., immunocompromised or post-transplant) and treatment of established fungal infections.

Enhanced Bioavailability – The gastro-resistant (GR) formulation ensures better absorption in the digestive tract, maximizing therapeutic effectiveness.

Convenient Oral Tablet – Allows at-home administration under medical guidance, improving patient compliance.

Therapeutic Use – Erlocip 150 contains Erlotinib, a targeted cancer therapy (tyrosine kinase inhibitor) used in the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer.

Targeted Action – Works by blocking the activity of the epidermal growth factor receptor (EGFR), thereby slowing down or stopping the growth of cancer cells.

Convenient Dosage – 150 mg tablet strength designed for once-daily oral administration as prescribed by an oncologist.

Proven Efficacy – Shown to improve survival rates and delay disease progression in EGFR-positive patients.